title: Inadvertent intrathecal injection of PEG-asparaginase.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Naqvi
authors.forename: Zehra
authors.initials: Z
authors.lastname: Fadoo
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects*; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects*; D008297:Male; D008508:Medication Errors; D011092:Polyethylene Glycols / Q000009:adverse effects*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D003561:Cytarabine; D011092:Polyethylene Glycols; C042705:pegaspargase; D001215:Asparaginase